Breaking News, Promotions & Moves

Boehringer Ingelheim U.S. CEO to Retire

Paul Fonteyne's last day will be December 31, 2018 after 15 years with the company

Boehringer Ingelheim announced today that Paul Fonteyne, U.S. president and chief executive officer, will retire after 15 years of employment on December 31, 2018. Wolfgang Baiker, M.D, Ph.D, M.B.A., has been appointed to succeed him.   Dr. Baiker, currently senior vice president, Human Pharma Supply & Global Quality and head of the Biopharma Business Unit, joined Boehringer Ingelheim in 1989 as section head for Clinical Development in Biberach, Germany. Since then, Dr. Baiker has se...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters